Office of the Chief Medical Examiner, 7007-116 Street NW, Edmonton, Alberta, Canada.
Office of the Chief Medical Examiner, 7007-116 Street NW, Edmonton, Alberta, Canada.
Forensic Sci Int. 2020 Apr;309:110215. doi: 10.1016/j.forsciint.2020.110215. Epub 2020 Feb 19.
This article compares 290 post mortem case reports that were positive for carfentanil. All the cases were submitted to, and analyzed by, the toxicology department of the Office of the Chief Medical Examiner, Edmonton, Alberta, Canada. This study highlights the varied distribution of carfentanil in the body after death as a result of misadventure, i.e., these are accidental drug overdose cases. Post mortem samples were collected from more than one anatomical site and analysed for carfentanil using a validated liquid chromatography-tandem mass spectrometry method. Ante-mortem samples were available in 15 of these cases and were also analysed. Post mortem mean blood carfentanil concentrations were found to be 0.362 μg/L (femoral), 0.442 μg/L (iliac), 0.484 μg/L (cardiac) and 0.692 μg/L (subclavian). The mean vitreous humor carfentanil concentration was 0.238 μg/L; the mean urine carfentanil concentration was found to be 0.697 μg/L. Little difference was found between ligated and 'blindstick' femoral blood carfentanil concentrations. Whilst carfentanil can readily be detected in both vitreous humor and urine samples neither were found to correlate with blood concentrations, limiting their use in interpretation. This study demonstrates the importance of multi-site sample collection and subsequent analysis for a thorough post mortem toxicological investigation. The study also highlights the risks and limitations associated with the interpretation of post mortem analytical results concerning carfentanil.
这篇文章比较了 290 例死后案例报告,这些案例报告均为阳性,表明存在卡芬太尼。所有案例均提交给加拿大阿尔伯塔省埃德蒙顿首席法医办公室毒理学部门,并由该部门进行分析。本研究强调了卡芬太尼在因意外、即意外药物过量情况下死后在体内的分布差异。死后样本来自多个解剖部位,并使用经过验证的液相色谱-串联质谱法对卡芬太尼进行分析。在这些案例中有 15 例存在生前样本,也对其进行了分析。发现死后平均血液卡芬太尼浓度分别为:股静脉 0.362μg/L、髂静脉 0.442μg/L、心腔 0.484μg/L 和锁骨下静脉 0.692μg/L。平均玻璃体液卡芬太尼浓度为 0.238μg/L;尿液卡芬太尼浓度为 0.697μg/L。结扎股静脉和“盲目穿刺”股静脉血卡芬太尼浓度之间差异不大。虽然卡芬太尼很容易在玻璃体液和尿液样本中检测到,但都发现与血液浓度无关,限制了其在解释中的应用。本研究表明多部位采样和随后的全面死后毒理学调查分析的重要性。该研究还强调了在解释与卡芬太尼有关的死后分析结果时存在的风险和限制。